102 related articles for article (PubMed ID: 20054093)
1. Screening histories of invasive breast cancers diagnosed 1989-2006 in the West Midlands, UK: variation with time and impact on 10-year survival.
Lawrence G; O'Sullivan E; Kearins O; Tappenden N; Martin K; Wallis M
J Med Screen; 2009; 16(4):186-92. PubMed ID: 20054093
[TBL] [Abstract][Full Text] [Related]
2. Are international differences in breast cancer survival between Australia and the UK present amongst both screen-detected women and non-screen-detected women? survival estimates for women diagnosed in West Midlands and New South Wales 1997-2006.
Woods LM; Rachet B; O'Connell DL; Lawrence G; Coleman MP
Int J Cancer; 2016 May; 138(10):2404-14. PubMed ID: 26756306
[TBL] [Abstract][Full Text] [Related]
3. The Scottish breast screening programme's experience of monitoring interval cancers.
Everington D; Gilbert FJ; Tyack C; Warner J
J Med Screen; 1999; 6(1):21-7. PubMed ID: 10321366
[TBL] [Abstract][Full Text] [Related]
4. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
5. The West Midlands breast cancer screening status algorithm - methodology and use as an audit tool.
Lawrence G; Kearins O; O'Sullivan E; Tappenden N; Wallis M; Walton J
J Med Screen; 2005; 12(4):179-84. PubMed ID: 16417694
[TBL] [Abstract][Full Text] [Related]
6. Interval cancers in the Dutch breast cancer screening programme.
Fracheboud J; de Koning HJ; Beemsterboer PM; Boer R; Verbeek AL; Hendriks JH; van Ineveld BM; Broeders MJ; de Bruyn AE; van der Maas PJ
Br J Cancer; 1999 Nov; 81(5):912-7. PubMed ID: 10555768
[TBL] [Abstract][Full Text] [Related]
7. The incidence of advanced breast cancer in the West Midlands, United Kingdom.
Autier P; Boniol M
Eur J Cancer Prev; 2012 May; 21(3):217-21. PubMed ID: 22314850
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer in East Anglia: the impact of the breast screening programme on stage at diagnosis.
McCann J; Stockton D; Day N
J Med Screen; 1998; 5(1):42-8. PubMed ID: 9575460
[TBL] [Abstract][Full Text] [Related]
9. Impact of deprivation on breast cancer survival among women eligible for mammographic screening in the West Midlands (UK) and New South Wales (Australia): Women diagnosed 1997-2006.
Woods LM; Rachet B; O'Connell D; Lawrence G; Coleman MP
Int J Cancer; 2016 May; 138(10):2396-403. PubMed ID: 26756181
[TBL] [Abstract][Full Text] [Related]
10. Interval breast cancers in the NHS Breast Screening Programme: does the current definition exclude too many?
Faux AM; Richardson DC; Lawrence GM; Wheaton ME; Wallis MG
J Med Screen; 1997; 4(3):169-73. PubMed ID: 9368875
[TBL] [Abstract][Full Text] [Related]
11. Improved survival rate for women with interval breast cancer - results from the breast cancer screening programme in Malmö, Sweden 1976-1999.
Zackrisson S; Janzon L; Manjer J; Andersson I
J Med Screen; 2007; 14(3):138-43. PubMed ID: 17925086
[TBL] [Abstract][Full Text] [Related]
12. Population estimates of survival in women with screen-detected and symptomatic breast cancer taking account of lead time and length bias.
Lawrence G; Wallis M; Allgood P; Nagtegaal ID; Warwick J; Cafferty FH; Houssami N; Kearins O; Tappenden N; O'Sullivan E; Duffy SW
Breast Cancer Res Treat; 2009 Jul; 116(1):179-85. PubMed ID: 18622697
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of the prevalent round of the breast screening programme in south east Thames, 1988-1993: achievement of quality standards and population impact.
Garvican L; Littlejohns P
J Med Screen; 1996; 3(3):123-8. PubMed ID: 8946306
[TBL] [Abstract][Full Text] [Related]
14. Do pre-diagnosis primary care consultation patterns explain deprivation-specific differences in net survival among women with breast cancer? An examination of individually-linked data from the UK West Midlands cancer registry, national screening programme and Clinical Practice Research Datalink.
Morris M; Woods LM; Bhaskaran K; Rachet B
BMC Cancer; 2017 Feb; 17(1):155. PubMed ID: 28231774
[TBL] [Abstract][Full Text] [Related]
15. Results from the NHS breast screening programme 1990-1993.
Moss SM; Michel M; Patnick J; Johns L; Blanks R; Chamberlain J
J Med Screen; 1995; 2(4):186-90. PubMed ID: 8719146
[TBL] [Abstract][Full Text] [Related]
16. [Nationwide breast cancer screening fully accomplished; results from the implementation phase 1990-1997. National Evaluation Team for Breast Cancer Screening].
Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1124-9. PubMed ID: 10876708
[TBL] [Abstract][Full Text] [Related]
17. Stage distribution of breast cancer diagnosed before and after implementation of population-based mammographic screening.
Hofvind S; Skaane P
Rofo; 2012 May; 184(5):437-42. PubMed ID: 22426937
[TBL] [Abstract][Full Text] [Related]
18. Results from the UK NHS Breast Screening Programme 2000-05.
Bennett RL; Blanks RG; Patnick J; Moss SM
J Med Screen; 2007; 14(4):200-4. PubMed ID: 18078565
[TBL] [Abstract][Full Text] [Related]
19. Results from the UK NHS breast screening programme 1994-1999.
Blanks RG; Moss SM; Patnick J
J Med Screen; 2000; 7(4):195-8. PubMed ID: 11202586
[TBL] [Abstract][Full Text] [Related]
20. Comparison of clinical-pathologic characteristics and outcomes of true interval and screen-detected invasive breast cancer among participants of a Canadian breast screening program: a nested case-control study.
Rayson D; Payne JI; Abdolell M; Barnes PJ; MacIntosh RF; Foley T; Younis T; Burns A; Caines J
Clin Breast Cancer; 2011 Mar; 11(1):27-32. PubMed ID: 21421519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
